Grant✓ Small businesses may apply

Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)

National Institutes of Health

Opportunity #: PAR-25-286
Agency: National Institutes of Health
ALN (CFDA): 93.242
Status: posted
Posted: Nov 21, 2024
Closes: Jan 7, 2028
Funding instrument: Grant
Category: Health
Cost sharing required: No

Who can apply

•Others (see text field entitled "Additional Information on Eligibility" for clarification)
•City or township governments
•Native American tribal organizations (other than Federally recognized tribal governments)
•Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
•State governments
•Private institutions of higher education
•Native American tribal governments (Federally recognized)
•Independent school districts
•Public and State controlled institutions of higher education
•Small businesses
•Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
•County governments
•Public housing authorities/Indian housing authorities
•Special district governments
•For profit organizations other than small businesses

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Synopsis

The purpose of this Notice of Funding Opportunity (NOFO) is to encourage applications seeking to develop the next generation of brain stimulation devices for treating mental health disorders. Applications are sought that will either 1) develop novel brain stimulation devices or 2) significantly enhance, by means of hardware/software improvements, the effectiveness of brain stimulation devices that are currently U.S. Food and Drug Administration (FDA)-approved or cleared. Novel devices should move beyond existing electrical/magnetic stimulation and develop new stimulation techniques capable of increased spatiotemporal precision as well as multi-focal, closed-loop approaches. Applications seeking to develop new capabilities should focus on significant enhancement of the spatial resolution, depth of delivery, and/or precision of the device. Incremental changes to existing devices (e.g., software updates)are not within the scope of this announcement. Applications should be submitted by multi-disciplinary teams with a variety of expertise including systems neuroscience, engineering, clinical, and regulatory affairs.

Contact

National Institutes of Health · grantsinfo@nih.gov

View full notice on Grants.gov ↗